Verve Therapeutics Proclaims Incentive Grants Underneath Nasdaq Itemizing Rule 5635(c)(4) By Investing.com
BOSTON, Jan. 03, 2025 (GLOBE NEWSWIRE) -- Verve Therapeutics, a clinical-stage firm…
LENSAR Declares Incentive Grants Beneath Nasdaq Itemizing Rule 5635(c)(4) By Investing.com
ORLANDO, Fla., Jan. 02, 2025 (GLOBE NEWSWIRE) -- LENSAR, Inc. (Nasdaq: LNSR)…
EyePoint Prescribed drugs Publicizes Incentive Grants Beneath NASDAQ Itemizing Rule 5635(c)(4) By Investing.com
WATERTOWN, Mass., Dec. 16, 2024 (GLOBE NEWSWIRE) -- EyePoint Prescribed drugs, Inc.…
